• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右肝和左肝超声衰减值检测在非酒精性脂肪性肝病肝脂肪变诊断中的性能比较。

Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease.

机构信息

Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Department of Medicine, Division of Gastroenterology & Hepatology, Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

Acad Radiol. 2023 Sep;30(9):1838-1845. doi: 10.1016/j.acra.2022.12.025. Epub 2022 Dec 29.

DOI:10.1016/j.acra.2022.12.025
PMID:36586759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10307925/
Abstract

RATIONALE AND OBJECTIVES

Non-alcoholic fatty liver disease (NAFLD) is currently diagnosed by liver biopsy or MRI proton density fat fraction (MRI-PDFF) from left hepatic lobe (LTHL) and/or right hepatic lobe (RTHL). The objective of this study was to compare the diagnostic value of ultrasound attenuation coefficients (ACs) from RTHL and LTHL in detecting hepatic steatosis using biopsy or MRI-PDFF as a reference standard.

MATERIALS AND METHODS

Sixty-six patients with suspected NAFLD were imaged with an Aplio i800 ultrasound scanner (Canon Medical Systems, Tustin, CA). Five AC measurements from RTHL and LTHL were averaged separately and together to be compared with the reference standard.

RESULTS

Forty-seven patients (71%) were diagnosed with NAFLD. Mean ACs were significantly higher in fatty livers than non-fatty livers (RTHL: 0.73 ± 0.10 vs. 0.63 ± 0.07 dB/cm/MHZ; p < 0.0001, LTHL: 0.78 ± 0.11 vs. 0.63 ± 0.06 dB/cm/MHz; p < 0.0001, RTHL & LTHL: 0.76 ± 0.09 vs. 0.63 ± 0.05 dB/cm/MHz; p < 0.0001). Biopsy steatosis grades (n =31) were better correlated with the mean ACs of RTHL & LTHL (r = 0.72) compared to LTHL (r = 0.67) or RTHL (r = 0.61). Correlation between MRI-PDFF (n = 35) and mean ACs was better for LTHL (r = 0.69) compared to the RTHL & LTHL (r = 0.66) or RTHL (r = 0.45). Higher diagnostic accuracy was shown for the mean ACs of RTHL & LTHL (AUC 0.89, specificity 94%, sensitivity 78%) compared to LTHL (AUC 0.89, specificity 88%, sensitivity 82%) or RTHL (AUC 0.81, specificity 89%, sensitivity 68%).

CONCLUSION

Ultrasound ACs from RTHL and LTHL showed comparable diagnostic values in detection of hepatic steatosis with the highest diagnostic accuracy when they were averaged together.

摘要

背景和目的

目前,非酒精性脂肪性肝病(NAFLD)通过肝活检或左肝叶(LTHL)和/或右肝叶(RTHL)的磁共振质子密度脂肪分数(MRI-PDFF)进行诊断。本研究的目的是比较 RTHL 和 LTHL 的超声衰减系数(AC)在使用肝活检或 MRI-PDFF 作为参考标准检测肝脂肪变性方面的诊断价值。

材料和方法

对 66 例疑似 NAFLD 的患者进行 Aplio i800 超声扫描仪(佳能医疗系统公司,美国加利福尼亚州图森市)成像。分别平均化 RTHL 和 LTHL 的 5 个 AC 测量值,然后与参考标准进行比较。

结果

47 例(71%)患者被诊断为 NAFLD。脂肪肝的平均 AC 值明显高于非脂肪肝(RTHL:0.73±0.10 与 0.63±0.07 dB/cm/MHZ;p<0.0001,LTHL:0.78±0.11 与 0.63±0.06 dB/cm/MHZ;p<0.0001,RTHL 和 LTHL:0.76±0.09 与 0.63±0.05 dB/cm/MHZ;p<0.0001)。肝活检脂肪变性程度(n=31)与 RTHL 和 LTHL 的平均 AC 值相关性更好(r=0.72),而与 LTHL(r=0.67)或 RTHL(r=0.61)的相关性较差。MRI-PDFF(n=35)与 LTHL 的平均 AC 值相关性更好(r=0.69),而与 RTHL 和 LTHL(r=0.66)或 RTHL(r=0.45)的相关性较差。RTHL 和 LTHL 的平均 AC 值显示出较高的诊断准确性(AUC 0.89,特异性 94%,敏感性 78%),优于 LTHL(AUC 0.89,特异性 88%,敏感性 82%)或 RTHL(AUC 0.81,特异性 89%,敏感性 68%)。

结论

RTHL 和 LTHL 的超声 AC 值在检测肝脂肪变性方面具有相当的诊断价值,当它们平均化时,具有最高的诊断准确性。

相似文献

1
Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease.右肝和左肝超声衰减值检测在非酒精性脂肪性肝病肝脂肪变诊断中的性能比较。
Acad Radiol. 2023 Sep;30(9):1838-1845. doi: 10.1016/j.acra.2022.12.025. Epub 2022 Dec 29.
2
Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease.定量超声参数在非酒精性脂肪性肝病中的诊断性能。
Acad Radiol. 2024 Jan;31(1):199-211. doi: 10.1016/j.acra.2023.07.001. Epub 2023 Jul 26.
3
Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study.超声剪切波衰减成像在志愿者和非酒精性脂肪性肝病患者肝脂肪变分级中的初步研究。
Ultrasound Med Biol. 2023 Oct;49(10):2264-2272. doi: 10.1016/j.ultrasmedbio.2023.06.020. Epub 2023 Jul 21.
4
Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds.利用不同波束形成声速提高超声纹理特征在检测和量化肝脂肪变性中的诊断准确性。
Phys Med Biol. 2023 Feb 17;68(4). doi: 10.1088/1361-6560/acb635.
5
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.磁共振成像质子密度脂肪分数作为参考标准的非酒精性脂肪性肝病肝脂肪变性的定量超声射频数据分析。
Korean J Radiol. 2021 Jul;22(7):1077-1086. doi: 10.3348/kjr.2020.1262. Epub 2021 Mar 9.
6
Liver Fat Quantification by Ultrasound in Children: A Prospective Study.超声在儿童肝脏脂肪定量中的应用:一项前瞻性研究。
AJR Am J Roentgenol. 2021 Oct;217(4):996-1006. doi: 10.2214/AJR.20.24874. Epub 2021 Jan 13.
7
Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.应用新型超声技术检测肝脏脂肪变:以 MRI 衍生质子密度脂肪分数为金标准的初步研究。
Clin Transl Gastroenterol. 2019 Oct;10(10):e00081. doi: 10.14309/ctg.0000000000000081.
8
Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.9 项定量超声参数在非酒精性脂肪性肝病患者肝脂肪变检测和分级中的诊断性能
Invest Radiol. 2022 Jan 1;57(1):23-32. doi: 10.1097/RLI.0000000000000797.
9
Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.FibroTouch 对以 MRI-PDFF 为参照标准诊断非酒精性脂肪性肝病患者肝脂肪变的价值。
J Dig Dis. 2023 Dec;24(12):691-701. doi: 10.1111/1751-2980.13242. Epub 2023 Dec 22.
10
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.磁共振质子密度脂肪分数成像对非酒精性脂肪性肝病患者肝脂肪变的诊断价值:一项荟萃分析。
Eur Radiol. 2019 Jul;29(7):3564-3573. doi: 10.1007/s00330-019-06072-4. Epub 2019 Mar 21.

引用本文的文献

1
Assessing Quality of Ultrasound Attenuation Coefficient Results for Liver Fat Quantification.评估用于肝脏脂肪定量的超声衰减系数结果的质量。
Diagnostics (Basel). 2024 Sep 29;14(19):2171. doi: 10.3390/diagnostics14192171.

本文引用的文献

1
US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.美国肝脏脂肪定量衰减校正:AIUM-RSNA QIBA 脉冲回波定量超声倡议。
Radiology. 2022 Mar;302(3):495-506. doi: 10.1148/radiol.210736. Epub 2022 Jan 25.
2
Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies.超声衰减系数评估肝脂肪变性的准确性:前瞻性研究的系统评价和荟萃分析
Ultrasonography. 2022 Jan;41(1):83-92. doi: 10.14366/usg.21076. Epub 2021 Jun 1.
3
Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
超声衰减成像技术在常规腹部超声检查中对肝脂肪变性的检出和严重程度分级的应用价值。
Clin Imaging. 2021 Aug;76:53-59. doi: 10.1016/j.clinimag.2021.01.034. Epub 2021 Feb 1.
4
Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.衰减成像技术在肝脂肪变性检测中的性能。
J Ultrasound Med. 2021 Jul;40(7):1325-1332. doi: 10.1002/jum.15512. Epub 2020 Sep 22.
5
Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.基于超声技术的衰减成像评估肝脂肪变性:与磁共振成像测定的质子密度脂肪分数的比较。
Hepatol Res. 2020 Dec;50(12):1319-1327. doi: 10.1111/hepr.13563. Epub 2020 Sep 15.
6
The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.肝脏多参数超声在非酒精性脂肪性肝炎评估中的作用。
Radiology. 2020 Sep;296(3):532-540. doi: 10.1148/radiol.2020192665. Epub 2020 Jun 23.
7
Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis.二维剪切波弹性成像和衰减成像技术评估非酒精性脂肪性肝炎患者的准确性。
Clin Gastroenterol Hepatol. 2021 Apr;19(4):797-805.e7. doi: 10.1016/j.cgh.2020.05.034. Epub 2020 May 22.
8
Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病肝脂肪变性诊断和监测的定量超声方法
Theranostics. 2020 Mar 4;10(9):4277-4289. doi: 10.7150/thno.40249. eCollection 2020.
9
Epidemiology of Non-alcoholic Fatty Liver Disease in North America.北美地区非酒精性脂肪性肝病的流行病学。
Curr Pharm Des. 2020;26(10):993-997. doi: 10.2174/1381612826666200303114934.
10
Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach.非酒精性脂肪性肝病自然史:对临床实践和个体化方法的启示。
Can J Gastroenterol Hepatol. 2020 Jan 21;2020:9181368. doi: 10.1155/2020/9181368. eCollection 2020.